MMS

MMS Holdings is an award-winning, global, and data-focused clinical research organization (CRO) that provides a comprehensive suite of services to the pharmaceutical, biotechnology, and medical device industries. Founded in 2006 by Dr. Uma Sharma, the company has grown from a one-person consultancy into a global enterprise with over 1,000 colleagues across four continents. MMS Holdings is dedicated to supporting its clients by navigating the complexities of clinical trial data and regulatory submissions with a proven, scientific approach. The company's core mission is to deliver high-quality service and technology solutions, rooted in strong science and decades of regulatory experience, to assist clients in developing and marketing life-changing therapies that positively impact patients' lives worldwide. This commitment is reflected in their industry-leading customer satisfaction rating and a track record of more than 50 successful marketing application submissions in the past five years with zero refusals to file.

MMS Holdings differentiates itself through a science-first approach, operational agility, and a profound sense of urgency and leadership (SOUL). The company offers a wide spectrum of services, including regulatory and medical writing, biostatistics, clinical programming, data management, pharmacovigilance, and clinical trial transparency. A key aspect of their innovative approach is the integration of technology, particularly through their proprietary Datacise® suite. This flexible, AI-driven toolkit is designed to optimize clinical trial design, manage Independent Data Monitoring Committees (IDMCs), detect safety signals, and manage data flow in near real-time. By leveraging advanced technologies like AI and machine learning, MMS Holdings aims to accelerate development timelines and de-risk clinical trials for its sponsors. The company's expertise spans a wide range of therapeutic areas, including oncology, rare diseases, immunology, and central nervous system disorders, making them a versatile and trusted partner for a diverse clientele, from top-ten pharmaceutical giants to smaller biotech firms.